Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 799

1.
3.
5.
7.

Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer.

Marcelli M, Cunningham GR, Walkup M, He Z, Sturgis L, Kagan C, Mannucci R, Nicoletti I, Teng B, Denner L.

Cancer Res. 1999 Jan 15;59(2):382-90.

8.
9.
10.
11.

Cytochrome c release and caspase-3 activation during colchicine-induced apoptosis of cerebellar granule cells.

Gorman AM, Bonfoco E, Zhivotovsky B, Orrenius S, Ceccatelli S.

Eur J Neurosci. 1999 Mar;11(3):1067-72.

PMID:
10103099
12.

Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation.

Marcelli M, Marani M, Li X, Sturgis L, Haidacher SJ, Trial JA, Mannucci R, Nicoletti I, Denner L.

Prostate. 2000 Mar 1;42(4):260-73.

PMID:
10679755
13.
14.
15.
16.

Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes.

Déas O, Dumont C, MacFarlane M, Rouleau M, Hebib C, Harper F, Hirsch F, Charpentier B, Cohen GM, Senik A.

J Immunol. 1998 Oct 1;161(7):3375-83.

17.

Se-methylselenocysteine induces apoptosis through caspase activation in HL-60 cells.

Kim T, Jung U, Cho DY, Chung AS.

Carcinogenesis. 2001 Apr;22(4):559-65.

18.
19.

Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells.

Park MT, Kang JA, Choi JA, Kang CM, Kim TH, Bae S, Kang S, Kim S, Choi WI, Cho CK, Chung HY, Lee YS, Lee SJ.

Clin Cancer Res. 2003 Feb;9(2):878-85.

20.

Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.

Marcelli M, Cunningham GR, Haidacher SJ, Padayatty SJ, Sturgis L, Kagan C, Denner L.

Cancer Res. 1998 Jan 1;58(1):76-83.

Items per page

Supplemental Content

Support Center